451 related articles for article (PubMed ID: 27628078)
1. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.
McCormack FX; Gupta N; Finlay GR; Young LR; Taveira-DaSilva AM; Glasgow CG; Steagall WK; Johnson SR; Sahn SA; Ryu JH; Strange C; Seyama K; Sullivan EJ; Kotloff RM; Downey GP; Chapman JT; Han MK; D'Armiento JM; Inoue Y; Henske EP; Bissler JJ; Colby TV; Kinder BW; Wikenheiser-Brokamp KA; Brown KK; Cordier JF; Meyer C; Cottin V; Brozek JL; Smith K; Wilson KC; Moss J;
Am J Respir Crit Care Med; 2016 Sep; 194(6):748-61. PubMed ID: 27628078
[TBL] [Abstract][Full Text] [Related]
2. Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.
Gupta N; Finlay GA; Kotloff RM; Strange C; Wilson KC; Young LR; Taveira-DaSilva AM; Johnson SR; Cottin V; Sahn SA; Ryu JH; Seyama K; Inoue Y; Downey GP; Han MK; Colby TV; Wikenheiser-Brokamp KA; Meyer CA; Smith K; Moss J; McCormack FX;
Am J Respir Crit Care Med; 2017 Nov; 196(10):1337-1348. PubMed ID: 29140122
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
[TBL] [Abstract][Full Text] [Related]
5. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
Harari S; Spagnolo P; Cocconcelli E; Luisi F; Cottin V
Curr Opin Pulm Med; 2018 Sep; 24(5):469-476. PubMed ID: 29927757
[TBL] [Abstract][Full Text] [Related]
7. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
[TBL] [Abstract][Full Text] [Related]
8. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Raghu G; Rochwerg B; Zhang Y; Garcia CA; Azuma A; Behr J; Brozek JL; Collard HR; Cunningham W; Homma S; Johkoh T; Martinez FJ; Myers J; Protzko SL; Richeldi L; Rind D; Selman M; Theodore A; Wells AU; Hoogsteden H; Schünemann HJ; ; ; ;
Am J Respir Crit Care Med; 2015 Jul; 192(2):e3-19. PubMed ID: 26177183
[TBL] [Abstract][Full Text] [Related]
9. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
Sobiecka M
Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
[TBL] [Abstract][Full Text] [Related]
11. Serum Vascular Endothelial Growth Factor D in Cystic Lung Disease.
Ataya A; Riley L; Brantly ML
JAMA; 2019 Jan; 321(4):401-402. PubMed ID: 30605217
[No Abstract] [Full Text] [Related]
12. The ERS guidelines for LAM: trying a rationale approach to a rare disease.
Johnson SR
Respir Med; 2010 Jul; 104 Suppl 1():S33-41. PubMed ID: 20451364
[TBL] [Abstract][Full Text] [Related]
13. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.
Radzikowska E; Jaguś P; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
Respir Med; 2015 Nov; 109(11):1469-75. PubMed ID: 26386638
[TBL] [Abstract][Full Text] [Related]
15. Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline.
Hayes D; Wilson KC; Krivchenia K; Hawkins SMM; Balfour-Lynn IM; Gozal D; Panitch HB; Splaingard ML; Rhein LM; Kurland G; Abman SH; Hoffman TM; Carroll CL; Cataletto ME; Tumin D; Oren E; Martin RJ; Baker J; Porta GR; Kaley D; Gettys A; Deterding RR
Am J Respir Crit Care Med; 2019 Feb; 199(3):e5-e23. PubMed ID: 30707039
[TBL] [Abstract][Full Text] [Related]
16. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
[TBL] [Abstract][Full Text] [Related]
17. The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.
El-Chemaly S; Henske EP
Expert Rev Respir Med; 2015 Apr; 9(2):195-204. PubMed ID: 25757365
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.
El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Peters E; Haughey M; Bienfang D; Jones AM; Julien-Williams P; Cui Y; Villalba JA; Bagwe S; Maurer R; Rosas IO; Moss J; Henske EP
Chest; 2017 Jun; 151(6):1302-1310. PubMed ID: 28192114
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of lymphangioleiomyomatosis].
Gao P; Huang R; Cai BQ; Liu HR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):306-9. PubMed ID: 15266836
[TBL] [Abstract][Full Text] [Related]
20. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
